- Home
- AUTL vs RM Comparison
AUTL vs RM Comparison
Compare AUTL & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | RM |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.2M | 390.4M |
| IPO Year | 2025 | 2011 |
Fundamental Metrics
Financial Performance| Metric | AUTL | RM |
|---|---|---|
| Price | $1.59 | $34.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $8.50 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 1.3M | 49.3K |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.12% |
| EPS Growth | N/A | ★ 7.49 |
| EPS | N/A | ★ 1.18 |
| Revenue | $10,120,000.00 | ★ $645,598,000.00 |
| Revenue This Year | $80.32 | $12.94 |
| Revenue Next Year | $53.96 | $8.97 |
| P/E Ratio | ★ N/A | $29.95 |
| Revenue Growth | ★ 496.00 | 9.70 |
| 52 Week Low | $1.18 | $26.06 |
| 52 Week High | $2.70 | $46.00 |
Technical Indicators
Market Signals| Indicator | AUTL | RM |
|---|---|---|
| Relative Strength Index (RSI) | 54.85 | 41.04 |
| Support Level | $1.39 | $33.47 |
| Resistance Level | $1.69 | $35.24 |
| Average True Range (ATR) | 0.09 | 1.65 |
| MACD | 0.01 | -0.59 |
| Stochastic Oscillator | 54.17 | 7.76 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.